Skip to main navigation Skip to search Skip to main content

Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis.

  • Ina Kötter*
  • , Manfred Zierhut
  • , Anja Eckstein
  • , Reinhard Vonthein
  • , Thomas Ness
  • , Ilhan Günaydin
  • , Bodo Grimbacher
  • , Sabine Blaschke
  • , Hans Hartmut Peter
  • , Lothar Kanz
  • , Nicole Stübiger
  • *Corresponding author for this work
  • University of Tubingen
Original languageEnglish
JournalAdvances in Experimental Medicine and Biology
Volume528
Pages (from-to)521-523
Number of pages3
ISSN0065-2598
Publication statusPublished - 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this